Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Application of superabsorbent polymers (SAP) as desiccants to dry maize and reduce aflatoxin contamination.

Mbuge DO, Negrini R, Nyakundi LO, Kuate SP, Bandyopadhyay R, Muiru WM, Torto B, Mezzenga R.

J Food Sci Technol. 2016 Aug;53(8):3157-3165. doi: 10.1007/s13197-016-2289-6. Epub 2016 Aug 24.

2.

Potential of the Desert Locust Schistocerca gregaria (Orthoptera: Acrididae) as an Unconventional Source of Dietary and Therapeutic Sterols.

Cheseto X, Kuate SP, Tchouassi DP, Ndung'u M, Teal PE, Torto B.

PLoS One. 2015 May 13;10(5):e0127171. doi: 10.1371/journal.pone.0127171. eCollection 2015.

3.

Analysis of partial recombinants in lentiviral vector preparations.

Kuate S, Marino MP, Reiser J.

Hum Gene Ther Methods. 2014 Apr;25(2):126-35. doi: 10.1089/hgtb.2013.015. Epub 2014 Feb 14.

4.

Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.

Demberg T, Brocca-Cofano E, Kuate S, Aladi S, Vargas-Inchaustegui DA, Venzon D, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, DiPasquale J, Ruprecht RM, Montefiori DC, Srivastava I, Barnett SW, Robert-Guroff M.

Virology. 2013 Jun 5;440(2):210-21. doi: 10.1016/j.virol.2013.02.024. Epub 2013 Mar 22.

5.

Elucidation of the biosynthesis of the di-C-glycosylflavone isoschaftoside, an allelopathic component from Desmodium spp. that inhibits Striga spp. development.

Hamilton ML, Kuate SP, Brazier-Hicks M, Caulfield JC, Rose R, Edwards R, Torto B, Pickett JA, Hooper AM.

Phytochemistry. 2012 Dec;84:169-76. doi: 10.1016/j.phytochem.2012.08.005. Epub 2012 Sep 4.

PMID:
22959223
6.

T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus.

Nabi G, Temchura V, Grossmann C, Kuate S, Tenbusch M, Überla K.

Retrovirology. 2012 May 14;9:42. doi: 10.1186/1742-4690-9-42.

7.

Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route.

Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M.

Clin Vaccine Immunol. 2012 May;19(5):629-37. doi: 10.1128/CVI.00010-12. Epub 2012 Mar 21.

8.

Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.

Xiao P, Patterson LJ, Kuate S, Brocca-Cofano E, Thomas MA, Venzon D, Zhao J, DiPasquale J, Fenizia C, Lee EM, Kalisz I, Kalyanaraman VS, Pal R, Montefiori D, Keele BF, Robert-Guroff M.

J Virol. 2012 Apr;86(8):4644-57. doi: 10.1128/JVI.06812-11. Epub 2012 Feb 15.

9.

Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains.

Hidajat R, Kuate S, Venzon D, Kalyanaraman V, Kalisz I, Treece J, Lian Y, Barnett SW, Robert-Guroff M.

Vaccine. 2010 May 21;28(23):3963-71. doi: 10.1016/j.vaccine.2010.03.046. Epub 2010 Apr 9.

10.

Time trends and regional differences in the prevalence of HIV infection among women attending antenatal clinics in 2 provinces in Cameroon.

Kuate S, Mikolajczyk RT, Forgwei GW, Tih PM, Welty TK, Kretzschmar M.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):258-64. doi: 10.1097/QAI.0b013e3181ab6d2e.

PMID:
19546813
11.

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.

Falkensammer B, Rubner B, Hiltgartner A, Wilflingseder D, Stahl Hennig C, Kuate S, Uberla K, Norley S, Strasak A, Racz P, Stoiber H.

Retrovirology. 2009 Jun 21;6:60. doi: 10.1186/1742-4690-6-60.

12.

Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.

Esimone CO, Grunwald T, Nworu CS, Kuate S, Proksch P, Uberla K.

Chemotherapy. 2009;55(2):119-26. doi: 10.1159/000194974. Epub 2009 Jan 21.

PMID:
19155620
13.

Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus.

Temchura VV, Tenbusch M, Nchinda G, Nabi G, Tippler B, Zelenyuk M, Wildner O, Uberla K, Kuate S.

Vaccine. 2008 Jul 4;26(29-30):3662-72. doi: 10.1016/j.vaccine.2008.04.069. Epub 2008 May 16.

PMID:
18538453
14.
15.

A simple chemical method for synthesizing malonyl hemiesters of 21-hydroxypregnanes, potential intermediates in cardenolide biosynthesis.

Pádua RM, Waibel R, Kuate SP, Schebitz PK, Hahn S, Gmeiner P, Kreis W.

Steroids. 2008 Apr;73(4):458-65. doi: 10.1016/j.steroids.2007.12.012. Epub 2007 Dec 23.

PMID:
18249427
16.
17.

Purification and characterization of malonyl-coenzyme A: 21-hydroxypregnane 21-O-malonyltransferase (Dp21MaT) from leaves of Digitalis purpurea L.

Kuate SP, Pádua RM, Eisenbeiss WF, Kreis W.

Phytochemistry. 2008 Feb;69(3):619-26. Epub 2007 Oct 22.

PMID:
17945319
18.

Atraumatic oral spray immunization with replication-deficient viral vector vaccines.

Stahl-Hennig C, Kuate S, Franz M, Suh YS, Stoiber H, Sauermann U, Tenner-Racz K, Norley S, Park KS, Sung YC, Steinman R, Racz P, Uberla K.

J Virol. 2007 Dec;81(23):13180-90. Epub 2007 Sep 26.

19.
20.
21.

Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.

Kuate S, Cinatl J, Doerr HW, Uberla K.

Virology. 2007 May 25;362(1):26-37. Epub 2007 Jan 26.

22.

Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors.

Monse H, Laufs S, Kuate S, Zeller WJ, Fruehauf S, Uberla K.

J Virol. 2006 Aug;80(16):8145-50.

23.

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.

Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K.

Virology. 2006 Jul 20;351(1):133-44. Epub 2006 Apr 17.

24.

Chemical composition and antidermatophytic properties of volatile fractions of hexanic extract from leaves of Cupressus lusitanica Mill. from Cameroon.

Kuiate JR, Bessière JM, Zollo PH, Kuate SP.

J Ethnopharmacol. 2006 Jan 16;103(2):160-5. Epub 2005 Sep 15.

PMID:
16169171
25.

Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.

Kuate S, Stefanou D, Hoffmann D, Wildner O, Uberla K.

J Gene Med. 2004 Nov;6(11):1197-205.

PMID:
15459964
26.

Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques.

Eisenblätter M, Stahl-Hennig C, Kuate S, Stolte N, Jasny E, Hahn H, Pope M, Tenner-Racz K, Racz P, Steinman RM, Uberla K, Ignatius R.

Vaccine. 2004 Sep 3;22(25-26):3295-302.

PMID:
15308352
27.

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.

Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M, Pöhlmann S.

J Virol. 2004 Jun;78(12):6134-42.

29.
30.

Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus.

Takehisa J, Harada Y, Ndembi N, Mboudjeka I, Taniguchi Y, Ngansop C, Kuate S, Zekeng L, Ibuki K, Shimada T, Bikandou B, Yamaguchi-Kabata Y, Miura T, Ikeda M, Ichimura H, Kaptué L, Hayami M.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1143-54.

PMID:
11522184

Supplemental Content

Support Center